Steven Prelack, Director at Galectin Therapeutics, holds 107.19K shares in Galectin Therapeutics (Ticker: GALT), holds ― shares in Pieris Pharmaceuticals (Ticker: PIRS), holds 24.48K shares in Aadi Bioscience (Ticker: AADI).
What is the percentage of profitable transactions made by Steven Prelack?
The percentage of profitable transactions made by Steven Prelack is ―.
What is the average return per transaction made by Steven Prelack?
The average return per transaction made by Steven Prelack is ―.
What stocks does Steven Prelack hold?
Steven Prelack holds: GALT, PIRS, AADI stocks.
What was Steven Prelack’s latest transaction?
Steven Prelack latest transaction was an Uninformative Buy of ―.
What was Steven Prelack's most profitable transaction?
Steven Prelack’s most profitable transaction was an Informative Sell of GALT stock on April 14, 2014. The return on the trade was 69.50%.
What is Steven Prelack's role in Galectin Therapeutics?
Steven Prelack's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.